Edwards Lifesciences unloaded its critical care business in a $4.2 billion sale to BD in June, and the structural heart company has been on a spending spree ever since.
Most recently, Edwards bought JC Medical from Singapore-based Genesis MedTech and made a $25 million equity investment in Genesis.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,